Table 2.

Analysis of non-specific inflammatory markers and other parameters analysed according to the clinical diagnosis

Parameters	Groups of children according to the clinical diagnosis			P
	Overweight/obesity n = 38	Asthma n = 16	Overweight/obesity and asthma n = 18
WBC	8.52 ± 2.32	7.31 ± 1.98	8.25 ± 2.02	** χ2 (2) = 3.955; p = 0.138
Eo	2.60 ± 2.35	6.46 ± 4.77	5.75 ± 2.79	** χ2 (2) = 17.992; p < 0.001*
CRP	3.92 ± 3.54	1.47 ± 2.56	3.93 ± 6.31	** χ2 (2) = 11.304; p = 0.004*
Fibrinogen	3.04 ± 0.46	2.52 ± 0.40	2.78 ± 0.41	*** F = 8.357; p = 0.001*
IgE	119.75 ± 189.11	374.02 ± 494.97	380.17 ± 333.39	** χ2 (2) = 19.566; p < 0.001*
FEV1	103.79 ± 10.59	97.21 ± 10.74	102.21 ± 12.36	** χ2 (2) = 3.221; p = 0.120
FVC	98.74 ± 9.89	95.99 ± 8.59	99.52 ± 8.47	*** F = 0.6735; p = 0.513
FEV1/FVC	99.01 ± 7.89	95.90 ± 8.92	96.47 ± 6.73	** χ2 (2) = 3.191; p = 0.203
PEF	85.24 ± 11.79	87.82 ± 27.28	82.18 ± 14.18	** χ2 (2) = 2.942; p = 0.230
FEF25	81.26 ± 22.41	71.04 ± 27.06	73.69 ± 21.38	*** F = 1.298; p = 0.280
FEV50	49.13 ± 13.99	55.76 ± 15.73	49.31 ± 17.02	*** F = 1.163; p = 0.319
FEV75	94.72 ± 17.14	81.74 ± 21.64	87.18 ± 17.73	** χ2 (2) = 8.172; p = 0.017*
FeNO (>20 ppb)	15.59 ± 9.93	43.83 ± 29.27	39.07 ± 25.01	** χ2 (2) = 16.738; p < 0.001*
BMI	30.38 ± 5.57	18.59 ± 2.01	28.83 ± 5.24	*** F = 33.249; p < 0.001*
WC	95.75 ± 19.69	39.06 ± 31.39	90.61 ± 11.09	**χ2 (2) = 36.427; p < 0.001*
WHR	0.94 ± 0.10	0.86 ± 0.07	0.94 ± 0.12	** χ2 (2) = 4.278; p = 0.118
SPT (positive)	4 (10.53%)	13 (81.25%)	16 (88.89%)	Yates correcting = 41.768; df = 4; p = 0.000001**
Bronchodilator test (positive)	7 (18.92%)	14 (87.50%)	16 (100%)	/

FeNo = fractional exhaled nitric oxide; BMI = body mass index; WC = waist circumference; WHR = waist-hip ratio;

^*p < 0.05;

^**Kruskal-Wallis H test;

^***One Way ANOVA test.